Pieris' Grant - II Round

Pieris raised a round of funding on February 08, 2012. Investors include Bundesministerium fur Bildung und Forschung.

Pieris is an independent, clinical-staged biotechnology company advancing its proprietary Anticalin technology to create differentiated drugs that are safer and more effective than conventional approa…

Articles about Pieris' Grant - II Round: